Bahar Seçil, Dal Teoman
Clinic of Ear Nose and Throat, Vehbi Koc Foundation American Hospital, İstanbul, Turkey.
J Int Adv Otol. 2018 Aug;14(2):341-343. doi: 10.5152/iao.2018.5030.
Langerhans cell histiocytosis (LCH) is a rare disease, which may involve various organ systems; therefore, it has multiple clinical manifestations.
We present the case of a 56-year-old woman admitted to Amerikan Hospital Ear-Nose and Throat outpatient clinic with a complaint of progressive hearing loss in both ears, which had started 10 years ago. She was treated with corticosteroids for 10 years until last year, 2017. Surgical exploration was performed and histologic evaluation revealed LCH.
LCH has clinical manifestations depending on the site of infiltration. In adults, isolated bilateral mastoid infiltration, as an initial symptom, is a very rare condition. With corticosteroid uptake, the period of initial symptom was 10 years in our patient, which is, as per our knowledge, the longest reported in literature. This infiltration may mimic acute or chronic infections of the ear. Therefore, LCH should be considered in the differential diagnose of patients who present with bilateral mastoid cavity disease.
朗格汉斯细胞组织细胞增多症(LCH)是一种罕见疾病,可累及多个器官系统,因此具有多种临床表现。
我们报告一例56岁女性,因双耳进行性听力下降10年,就诊于美国医院耳鼻喉门诊。直到2017年去年,她接受了10年的皮质类固醇治疗。进行了手术探查,组织学评估显示为LCH。
LCH的临床表现取决于浸润部位。在成人中,以孤立性双侧乳突浸润为首发症状是非常罕见的情况。在我们的患者中,使用皮质类固醇后,首发症状持续了10年,据我们所知,这是文献报道中最长的。这种浸润可能类似于急性或慢性感染。因此,对于出现双侧乳突腔疾病的患者,鉴别诊断时应考虑LCH。